Sorrento Therapeutics, Inc. — Form D

Sorrento Therapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-22. The offering totals $1.9M, of which $1.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Emst-Gunter G AftingDirectorSan Diego, CA
Voung M Dr. TrieuDirectorSan Diego, CA
Cam G GallagherDirectorSan Diego, CA
Kim G JandaDirectorSan Diego, CA
Henry JiDirectorPalo Alto, CA
Scott M SalkaDirectorSan Diego, CA
Jaisim M ShahDirectorSan Diego, CA
David G WebbDirectorSan Diego, CA
Voung M Dr. TrieuExecutive OfficerSan Diego, CA
Henry JiExecutive OfficerPalo Alto, CA
George M UyExecutive OfficerSan Diego, CA
Richard G VincentExecutive OfficerSan Diego, CA
Antonius SchuhDirectorSan Diego, CA
Antonius SchuhExecutive OfficerSan Diego, CA
Curtis LockshinDirectorFramingham, MA
Ernst-Guenter AftingDirectorLos Altos, CA
Lewis J ShusterDirectorSan Diego, CA
Glenn L HalprynDirectorIrvine, CA
Richard G VincentDirectorSan Diego, CA
Kim D JandaDirectorSan Diego, CA
Ernst-Gunter G AftingDirectorSan Diego, CA
M. Scott SalkaDirectorSan Diego, CA
Henry Ji, Ph.D.DirectorSan Diego, CA
Henry Ji, Ph.D.Executive OfficerSan Diego, CA
Jane H Hsiao, Ph.D., MBADirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2013-03-28D$10.0M$6.4M
2012-01-11D$2.0M$2.0M
2009-09-24D$7.5M$7.5M
2009-09-24D$2.0M$2.0M

More